Atul
- Market Cap
- ₹14,889 Cr
- P/E
- 19.29
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 14.90%
- Debt to Equity
- 0.03
- EPS (TTM)
- ₹262.19
- Book Value
- ₹2,235.94
- Market Cap
- ₹14,889 Cr
- P/E (TTM)
- 19.29
- P/B
- 2.26
- ROE
- 11.50%
- Dividend Yield
- 0.59%
- EBITDA
- ₹1,234 Cr
- 52W High
- ₹7,180.00
- 52W Low
- ₹4,960.00
- Day Range
- ₹4,960.00 – ₹5,125.00
- Volume
- 48,154
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| 1,620.00 | 61.46 | 1,64,897 | 14.71 | 1.41% | 23.90% | 31.00% | 16,142 | 2,718 | |
| 4,932.70 | 80.98 | 54,186 | 6.46 | 0.06% | 7.82% | 9.64% | 5,853 | 661 | |
| 10,077.00 | 56.75 | 51,687 | 11.58 | 0.08% | 19.80% | 21.00% | 4,066 | 910 | |
| 1,620.30 | 86.28 | 21,506 | 8.29 | 0.00% | 9.66% | 11.90% | 1,298 | 249 | |
| 1,531.20 | 19.66 | 20,885 | 3.23 | 0.48% | 9.82% | 11.40% | 9,749 | 1,063 | |
| 5,488.50 | 34.93 | 16,828 | 5.74 | 0.20% | 16.60% | 21.50% | 2,604 | 481 | |
| 449.50 | 27.49 | 16,299 | 2.60 | 0.22% | 7.17% | 6.86% | 10,579 | 593 | |
| 5,057.00 | 19.29 | 14,889 | 2.26 | 0.60% | 11.50% | 14.90% | 6,969 | 788 | |
| Median 8 companies | 3,276.50 | 45.84 | 21,195 | 6.10 | 0.21% | 10.66% | 13.40% | 6,411 | 725 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 61
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 65
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 61
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 82
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 12
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 51
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 9.23% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 5 | 3 |
| Oscillators | Bullish | 1 | 5 | 3 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 31.25
- Neutral
- MACD (12,26,9)
- −188.74
- Bullish
- SMA (50)
- 5,696.21
- Bearish
- SMA (200)
- 6,336.98
- Bearish
As of
Analyst Rating
8 of 11 analysts rate Buy, 2 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +9.23% |
|---|---|
| 5Y | +10.95% |
| 3Y | +4.95% |
| 1Y | +12.38% |
| TTM | +18.14% |
Net profit
| 10Y | +9.66% |
|---|---|
| 5Y | +0.86% |
| 3Y | +10.77% |
| 1Y | +38.08% |
| TTM | +40.46% |
Operating cash flow
| 10Y | +9.82% |
|---|---|
| 5Y | +7.34% |
| 3Y | +13.11% |
| 1Y | +69.65% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.28 pp |
|---|---|
| 5Y | −8.12 pp |
| 3Y | +1.61 pp |
| 1Y | +0.04 pp |
| TTM | +0.67 pp |
Revenue by year
| Mar 2017 | ₹2,834 Cr |
|---|---|
| Mar 2018 | ₹3,514 Cr |
| Mar 2019 | ₹4,038 Cr |
| Mar 2020 | ₹4,093 Cr |
| Mar 2021 | ₹3,731 Cr |
| Mar 2022 | ₹5,081 Cr |
| Mar 2023 | ₹5,428 Cr |
| Mar 2024 | ₹4,726 Cr |
| Mar 2025 | ₹5,583 Cr |
| Mar 2026 | ₹6,274 Cr |
Net profit by year
| Mar 2017 | ₹323 Cr |
|---|---|
| Mar 2018 | ₹281 Cr |
| Mar 2019 | ₹436 Cr |
| Mar 2020 | ₹671 Cr |
| Mar 2021 | ₹660 Cr |
| Mar 2022 | ₹605 Cr |
| Mar 2023 | ₹507 Cr |
| Mar 2024 | ₹324 Cr |
| Mar 2025 | ₹499 Cr |
| Mar 2026 | ₹689 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
As of 2026-11-19, Atul Ltd trades at ₹5,064 with a market cap of ₹14,909.3 Cr and a PE of 19.31x. The company is virtually debt-free with a debt-to-equity ratio of 0.03, and TTM profit growth has surged to 42%, though the stock has declined 16% over the past year and sits near its 52-week low of ₹4,995 against a 52-week high of ₹7,180.
- Atul is almost debt-free with a debt-to-equity ratio of just 0.03, providing significant financial flexibility and resilience against interest rate cycles.
- TTM profit growth stands at 42%, marking a sharp acceleration compared to the 5-year compounded profit growth of just 1%, suggesting a meaningful earnings recovery underway.
- TTM sales growth of 18% is well above the 3-year compounded sales growth of 5% and the 10-year CAGR of 9%, indicating improving demand or pricing power.
- The PE ratio of 19.31x, combined with 42% TTM profit growth, implies the stock is trading at a relatively modest earnings multiple relative to its recent earnings momentum.
- 10-year compounded profit and sales growth of 9% each demonstrate a long track record of steady expansion through multiple business cycles.
- ROCE of 13.54% as of 2026-11-19 reflects reasonable capital efficiency for a specialty chemicals business with minimal leverage.
- The price-to-book ratio of 2.26x is moderate for a specialty chemicals company, suggesting the stock is not trading at an extreme premium to its asset base.
- The stock has delivered a negative 1-year return of -16% and a 5-year CAGR of -10%, indicating sustained underperformance over medium-to-long timeframes.
- 5-year compounded profit growth of only 1% highlights a prolonged period of earnings stagnation despite the recent TTM recovery.
- 3-year average ROE of approximately 9% is below the 10-year average of 13%, pointing to a structural decline in return generation efficiency over recent years.
- 5-year compounded sales growth of 11% has been described as poor for a company of this profile, and 3-year compounded sales growth has further decelerated to just 5%.
- Current ROE of 10.95% and last year ROE of 11% remain well below the 10-year average ROE of 13%, suggesting the business has not fully recovered its historical profitability profile.
- Dividend yield of just 0.6% offers limited income support for shareholders during periods of capital depreciation such as the current drawdown.
- The 3-year stock CAGR of -8% indicates that the recent TTM earnings recovery has not yet translated into sustained shareholder value creation.
- As a commodities-sector company, Atul remains exposed to raw material price volatility and cyclical demand patterns that could reverse the recent earnings uptick.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Limited recent news flow for Atul Ltd. The company continues executing its share buyback program at a steady pace, with roughly 39% of the total buyback amount utilised so far. No material headwinds or positive catalysts have emerged in the latest coverage, leaving the near-term outlook dependent on broader commodity sector trends and upcoming quarterly results.
- Ongoing share buyback program Nov 20
Atul Ltd bought back 700 shares on Nov 20 at an average price of ₹5,051.93, bringing cumulative buyback to 67,500 shares worth ₹35.02 crore. Remaining buyback capacity stands at ₹54.98 crore out of the total program.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,194 | 1,138 | 1,212 | 1,322 | 1,393 | 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 | 1,848 | 1,877 |
| Expenses | 1,039 | 986 | 1,065 | 1,099 | 1,150 | 1,193 | 1,229 | 1,242 | 1,284 | 1,327 | 1,389 | 1,454 | 1,630 |
| Operating Profit | 155 | 152 | 148 | 223 | 243 | 224 | 223 | 236 | 267 | 247 | 281 | 394 | 247 |
| OPM % | 13% | 13% | 12% | 17% | 17% | 16% | 15% | 16% | 17% | 16% | 17% | 21% | 13% |
| Other Income | 24 | 15 | 16 | 16 | 35 | 19 | 48.7 | 26.24 | 48.5 | 38.59 | 89.57 | 35 | 48.4 |
| Interest | 2 | 2 | 5 | 5 | 9 | 4 | 5 | 5 | 5 | 4 | 4 | 4 | 4 |
| Depreciation | 54 | 61 | 76 | 77 | 78 | 81 | 82 | 82 | 81 | 80 | 79 | 78 | 78 |
| PBT | 124 | 105 | 83 | 158 | 191 | 158 | 185 | 175 | 230 | 203 | 289 | 347 | 214 |
| Tax % | 26% | 32% | 29% | 29% | 27% | 26% | 30% | 25% | 21% | 20% | 27% | 27% | 26% |
| Net Profit | 91 | 72 | 59 | 112 | 140 | 117 | 130 | 132 | 182 | 164 | 211 | 254 | 159 |
| EPS (₹) | 30.60 | 24.04 | 19.84 | 38.00 | 46.47 | 36.93 | 42.97 | 43.40 | 60.88 | 54.60 | 71.38 | 83.32 | 52.89 |
| YoY Sales growth | −20 | −10 | 1 | 12 | 17 | 25 | 20 | 12 | 11 | 11 | 15 | 25 | 21 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,637 | 2,595 | 2,834 | 3,514 | 4,038 | 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | 5,583 | 6,274 | 6,969 |
| Expenses | 2,235 | 2,134 | 2,324 | 3,008 | 3,270 | 3,191 | 2,813 | 4,168 | 4,620 | 4,086 | 4,665 | 5,240 | 5,801 |
| Operating Profit | 402 | 461 | 510 | 505 | 768 | 902 | 918 | 913 | 807 | 639 | 918 | 1,034 | 1,168 |
| OPM % | 15% | 18% | 18% | 14% | 19% | 22% | 25% | 18% | 15% | 14% | 16% | 16% | 17% |
| Other Income | 9 | 37 | 57 | 30 | 38 | 83 | 109 | 76 | 86 | 65 | 115 | 206 | 217 |
| Interest | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 | 17 | 16 |
| Depreciation | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 317 | 322 | 315 |
| PBT | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 802 | 688 | 451 | 692 | 900 | 1,053 |
| Tax % | 31% | 32% | 28% | 32% | 36% | 21% | 25% | 25% | 26% | 28% | 28% | 23% | — |
| Net Profit | 240 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | 499 | 689 | 787 |
| EPS (₹) | 81.13 | 92.44 | 108.88 | 93.21 | 145.72 | 224.69 | 221.64 | 204.23 | 174.19 | 109.71 | 164.37 | 230.25 | 262.19 |
| Div. Payout % | 10% | 9% | 9% | 13% | 10% | 12% | 9% | 12% | 19% | 18% | 15% | 13% | — |
| Sales growth | 8 | −2 | 9 | 24 | 15 | 1 | −9 | 36 | 7 | −13 | 18 | 12 | 18 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 | 29 |
| Reserves | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 | 5,569 | 6,192 | 6,554 |
| Borrowings | 299 | 316 | 168 | 16 | 55 | 108 | 127 | 144 | 52 | 237 | 202 | 183 | 169 |
| Other Liabilities | 485 | 535 | 591 | 749 | 783 | 880 | 982 | 1,117 | 1,028 | 1,104 | 1,179 | 1,465 | 1,666 |
| Total Liabilities | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 | 8,418 |
| Fixed Assets | 514 | 750 | 1,026 | 1,027 | 1,104 | 1,125 | 1,418 | 1,634 | 1,770 | 2,792 | 2,847 | 2,676 | 2,656 |
| CWIP | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 420 | 1,033 | 281 | 124 | 110 | 122 |
| Investments | 66 | 382 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,392 | 1,766 | 2,592 | 2,808 |
| Other Assets | 1,131 | 1,154 | 1,210 | 1,415 | 1,515 | 1,513 | 1,906 | 2,297 | 2,068 | 1,990 | 2,242 | 2,492 | 2,833 |
| Total Assets | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 | 8,418 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | 603 | 1,023 |
| Investing | −167 | −375 | −175 | −129 | −408 | −782 | −645 | −163 | −469 | −683 | −494 | −891 |
| Financing | −124 | −39 | −212 | −207 | −1 | −111 | −52 | −57 | −257 | 38 | −118 | −98 |
| Net Cash Flow | 16 | −13 | 5 | 19 | −5 | −11 | 21 | 11 | −20 | 22 | −9 | 34 |
| Free Cash Flow | 111 | 31 | 180 | 213 | 195 | 508 | 396 | −359 | −167 | 164 | 334 | 851 |
| CFO/EBITDA | 95 | 111 | 93 | 91 | 86 | 122 | 100 | 47 | 112 | 121 | 82 | 113 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 62 | 67 | 75 | 63 | 64 | 72 | 71 | 57 | 72 | 74 | 74 |
| Inventory Days | 105 | 118 | 107 | 83 | 89 | 93 | 128 | 122 | 101 | 90 | 97 | 90 |
| Days Payable | 69 | 87 | 86 | 93 | 66 | 88 | 121 | 90 | 69 | 84 | 82 | 94 |
| Cash Conversion Cycle | 97 | 93 | 88 | 66 | 86 | 69 | 78 | 103 | 89 | 77 | 89 | 70 |
| Working Capital Days | 50 | 46 | 65 | 76 | 74 | 59 | 65 | 77 | 68 | 69 | 77 | 69 |
| ROCE % | 26% | 26% | 23% | 19% | 27% | 28% | 24% | 19% | 15% | 9% | 13% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Atul insights
67 extracted metrics across FY04–FY27.
Documents
- 23 Oct 2026
- 24 Jul 2026
- 24 Apr 2026
- 7 Oct 2026
- 1 Oct 2025
- 10 Oct 2024
- 24 Aug 2023
- 3 Aug 2022
- General announcements 19 Nov 2026
- General announcements 19 Nov 2026
- General announcements 18 Nov 2026
- General announcements 17 Nov 2026
Frequently Asked Questions about Atul
What does Atul Ltd do?
Where is Atul Ltd (ATUL) listed?
Which sector does Atul Ltd belong to?
What is the market capitalisation of Atul Ltd?
What is the PE ratio of Atul Ltd?
What is the 52-week high and low of Atul Ltd?
Does Atul Ltd pay dividends?
What is the Return on Equity (ROE) of Atul Ltd?
Company Information
Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ATUL.md for Atul Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.